Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record displays details for the GB5121 trial in adults with relapsed or refractory CNS lymphoma, including its termination and that the dose-expansion and Phase 2 parts were not initiated.
    Difference
    53%
    Check dated 2026-11-07T13:38:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T14:30:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” in its content.
    Difference
    1%
    Check dated 2026-10-24T18:42:50.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T18:39:27.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T19:13:52.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown, replacing the study record content and indicating that access to the page is blocked.
    Difference
    17%
    Check dated 2026-09-19T19:13:48.000Z thumbnail image

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.